SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Ounce who wrote (712)4/19/2001 10:59:15 PM
From: greedsgd_2000   of 746
 
Excellent article

However it seems to overstate the extent to which Venter and other researchers assumed proteomics was somehow irrelevant. No question that proteomics is the ultimate "Holy Grail" but of course 1000 times more complicated than the genomic project, and that is why Celera is now gearing up for a focused targeted assault in proteomics. (versus the MYGN/Hitachi approach of mapping all proteins)

Note Venter recently has been talking of upcoming computer designs with PEDA-crunch capability -ie 1000 trillion bits/sec SUPERCOMPUTERS. They will be needed soon to BEGIN to resolve some of these proteomic issues.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News